GADO, FRANCESCA
GADO, FRANCESCA
Dipartimento di Scienze Farmaceutiche
Achillea moschata Wulfen: From Ethnobotany to Phytochemistry, Morphology, and Biological Activity
2022 M. Bottoni, G. Baron, F. Gado, F. Milani, L. Santagostini, L. Colombo, P. Sira Colombo, E. Caporali, A. Spada, M. Biagi, C. Giuliani, P. Bruschi, G. Aldini, G. Fico
Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice
2021 L. Shapiro, F. Gado, C. Manera, A. Escayg
Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: Implications for drug discovery
2019 F. Gado, S. Meini, S. Bertini, M. Digiacomo, M. Macchia, C. Manera
Anti-inflammatory activity of a cb2 selective cannabinoid receptor agonist: Signaling and cytokines release in blood mononuclear cells
2022 A. Capozzi, D. Caissutti, V. Mattei, F. Gado, S. Martellucci, A. Longo, S. Recalchi, V. Manganelli, G. Riitano, T. Garofalo, M. Sorice, C. Manera, R. Misasi
Bergamot leaf extract treats cardiorenal metabolic syndrome and associated pathophysiological factors in rats fed with a high sugar fat diet
2022 J. Silva Siqueira, T. Aparecida Vieira, E. Tiemi Nakandakare-Maia, T. Luiz Novaga Palacio, F. Sarzi, J. Leite Garcia, B. Henrique de Paula, S. Garcia Zanati Bazan, G. Baron, L. Tucci, E. Janda, A.A. Altomare, F. Gado, A. Junio Togneri Ferron, G. Aldini, F. Valentini Francisqueti-Ferron, C. Renata Correa
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators
2022 F. Gado, C. Ceni, R. Ferrisi, G. Sbrana, L.A. Stevenson, M. Macchia, R.G. Pertwee, S. Bertini, C. Manera, G. Ortore
Chemical, Nutritional and Biological Evaluation of a Sustainable and Scalable Complex of Phytochemicals from Bergamot By-Products
2023 L. Della Vedova, F. Gado, T.A. Vieira, N.A. Grandini, T.L.N. Palácio, J.S. Siqueira, M. Carini, E. Bombardelli, C.R. Correa, G. Aldini, G. Baron
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells
2016 S. Fogli, C. Arena, S. Carpi, B. Polini, S. Bertini, M. Digiacomo, F. Gado, A. Saba, G. Saccomanni, M.C. Breschi, P. Nieri, C. Manera, M. Macchia
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R)
2022 R. Ferrisi, F. Gado, B. Polini, C. Ricardi, K.A. Mohamed, L.A. Stevenson, G. Ortore, S. Rapposelli, G. Saccomanni, R.G. Pertwee, R.B. Laprairie, C. Manera, G. Chiellini
Design, Synthesis, and Biological Activity of New {CB}2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands
2022 F. Gado, R. Ferrisi, B. Polini, K.A. Mohamed, C. Ricardi, E. Lucarini, S. Carpi, F. Domenichini, L.A. Stevenson, S. Rapposelli, G. Saccomanni, P. Nieri, G. Ortore, R.G. Pertwee, C. Ghelardini, L. Di Cesare Mannelli, G. Chiellini, R.B. Laprairie, C. Manera
Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile
2021 S. Sestito, A. Bacci, S. Chiarugi, M. Runfola, F. Gado, E. Margheritis, S. Gul, M.E. Riveiro, R. Vazquez, S. Huguet, C. Manera, K. Rezai, G. Garau, S. Rapposelli
Identification of the First Synthetic Allosteric Modulator of the CB 2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief
2019 F. Gado, L. Di Cesare Mannelli, E. Lucarini, S. Bertini, E. Cappelli, M. Digiacomo, L.A. Stevenson, M. Macchia, T. Tuccinardi, C. Ghelardini, R.G. Pertwee, C. Manera
Liquid Chromatography–High-Resolution Mass Spectrometry (LC-HRMS) Profiling of Commercial Enocianina and Evaluation of Their Antioxidant and Anti-Inflammatory Activity
2022 L. DELLA VEDOVA, G. Ferrario, F. Gado, A.A. Altomare, M. Carini, P. Morazzoni, G. Aldini, G. Baron
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases
2021 R. Ferrisi, C. Ceni, S. Bertini, M. Macchia, C. Manera, F. Gado
Modification on the 1,2-dihydro-2-oxo-pyridine-3-carboxamide core to obtain multi-target modulators of endocannabinoid system
2020 F. Gado, C. Arena, C.L. Fauci, I. Reynoso-Moreno, S. Bertini, M. Digiacomo, S. Meini, G. Poli, M. Macchia, T. Tuccinardi, J. Gertsch, A. Chicca, C. Manera
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2
2023 R. Ferrisi, B. Polini, C. Ricardi, F. Gado, K.A. Mohamed, G. Baron, S. Faiella, G. Poli, S. Rapposelli, G. Saccomanni, G. Aldini, G. Chiellini, R.B. Laprairie, C. Manera, G. Ortore
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor
2017 S. Bertini, A. Chicca, F. Gado, C. Arena, D. Nieri, M. Digiacomo, G. Saccomanni, P. Zhao, M.E. Abood, M. Macchia, J. Gertsch, C. Manera
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer
2018 B. Polini, M. Digiacomo, S. Carpi, S. Bertini, F. Gado, G. Saccomanni, M. Macchia, P. Nieri, C. Manera, S. Fogli
Phenolic compounds in prevention and treatment of skin cancers: A review
2021 F. Gado, M. Digiacomo, J.E. Salsano, M. Macchia, C. Manera
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system
2018 A. Chicca, C. Arena, S. Bertini, F. Gado, E. Ciaglia, M. Abate, M. Digiacomo, M. Lapillo, G. Poli, M. Bifulco, M. Macchia, T. Tuccinardi, J. Gertsch, C. Manera